CONGRESS, GRAPPLING WITH Contaminated CHINESE DRUGS, IS Obstructed BY LACK OF FDA Omission IN U.S. PHARMACEUTICAL SUPPLY CHAIN

Following significant reviews of Chinese-produced prescriptions that contained cancer-causing fixings, Congress is seriously investigating the U.S. store network of nonexclusive medications. Around 80 percent of producers that make key elements for the household medication market is situated outs...